Acquired Resistance to Immune Checkpoint Inhibitors
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference111 articles.
1. Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation;Abdallah;Lung Cancer (Auckl),2018
2. Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer;Anagnostou;Cancer Discov.,2017
3. Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis;Antonia;Lancet Oncol.,2019
4. Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial;Armand;J. Clin. Oncol.,2018
5. Transcriptional mechanisms of resistance to anti-PD-1 therapy;Ascierto;Clin. Cancer Res.,2017
Cited by 425 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors;Journal for ImmunoTherapy of Cancer;2024-02
2. Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors;ESMO Open;2024-02
3. Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction;Bioorganic & Medicinal Chemistry Letters;2024-02
4. Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy;Cell Reports;2024-02
5. CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer;npj Precision Oncology;2024-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3